AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Updated results of a phase 1 study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC; SGNS40-001).

Andrew L. Coveler,Martin Gutierrez,Gina M. Vaccaro, Ursa Brown-Glaberman,Juneko E. Grilley-Olson,Hedy L. Kindler,Mark Zalupski,Elisabeth I. Heath, Sarina A. Piha-Paul, Allison Wehr,Hailing Lu, Jonathan Hayman,David L. Bajor

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览9
暂无评分
关键词
metastatic pancreatic ductal adenocarcinoma,pembrolizumab,nab-paclitaxel
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要